Hundreds linked up to have their picture taken with Will Flanary, M.D., an ophthalmlogist in Portland, Oregon, and a hugely ...

Results from the phase 3 NOTUS trial presented at the ATS meeting confirm benefits of Dupixent (dupilumab) among 20% to 40% ...

A new study in JAMA Network Open suggests that disparities in outcomes between Black and White children with acute myeloid ...

Pamrevlumab is the third investigational agent to fail in a phase 3 trials. Researchers said It may be time to stop treating ...

Breast cancer stats from the American Association for Cancer Research 2024 Cancer Disparities Report. Although there has been ...

New study finds that daytime heat waves were associated with 19% higher odds of children’s asthma hospital visits. Longer ...

Hundreds linked up to have their picture taken with Will Flanary, M.D., an ophthalmlogist in Portland, Oregon, and a hugely ...

The FDA has approved a new type of bispecific antibody to treat small cell lung cancer and an additional indication for ...

William Flanary, M.D.., has a huge social media following as Dr. Glaucomflecken, a character he created on Twitter when he ...

Medicare patients who have pulmonary arterial hypertension and who are eligible for the low-income subsidy often have ...

The study found that the average annual costs for individuals with Chronic lymphocytic leukemia (CLL) were significantly ...

But the waivers that allow for coverage of tele-health expire at the end the year. Several bills have been put forth to ...